MAZE Maze Therapeutics31.81-17.19 (-35.1%)
Premarket Decliner
MAZE Maze Therapeutics49.000.000.0%
Premarket:41.00-8.00 (-16.3%)
Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
Globe NewswireWed, 25-Mar 7:00 AM